Could soluble urokinase plasminogen receptor (suPAR) be used as a diagnostic biomarker for ventilator-associated pneumonia?

Sünnetçioğlu A. , Sünnetçioğlu M. , Adiyaman F., Binici I. , Soyoral L.

CLINICAL RESPIRATORY JOURNAL, cilt.11, sa.6, ss.925-930, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 11 Konu: 6
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1111/crj.12438
  • Dergi Adı: CLINICAL RESPIRATORY JOURNAL
  • Sayfa Sayıları: ss.925-930

Özet

BackgroundSoluble urokinase plasminogen activator receptor (suPAR) is a biomarker that is increasingly used for evaluation of systemic inflammation. This study was performed to investigate whether suPAR may possess a diagnostic value in patients with ventilator-associated pneumonia (VAP).